ProfileGDS5822 / ILMN_1251679
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 33% 3% 35% 24% 29% 24% 26% 41% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 116.333
GSM1276600PDAC Late Ablation Control 28.63
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 114.835
GSM1276603PDAC Late Ablation 213.424
GSM1276604PDAC Late Ablation 315.129
GSM1303940PDAC Late Ablation_anti-CTLA4 113.824
GSM1303941PDAC Late Ablation_anti-CTLA4 21326
GSM1303942PDAC Late Ablation_anti-CTLA4 319.841